In addition, BD-138T parental tumor tissues showed significantly activated SRC and AKT, suggesting these pathways as druggable targets specific to concomitantly EGFR-amplified and PTEN-deleted MIBCs (Figure 4B). The gene discussed is AKT1; the disease is neoplasm.